[{"address1": "5750 Explorer Drive", "address2": "Suite 404", "city": "Mississauga", "state": "ON", "zip": "L4W 0A9", "country": "Canada", "phone": "905 602 5840", "website": "https://www.cipherpharma.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. It offers Epuris (isotretinoin), an oral retinoid indicated for the treatment of severe nodular and/or inflammatory acne, acne conglobate, and recalcitrant acne; Actikerall, a topical solution indicated for the treatment of slightly palpable and/or moderately thick hyperkeratotic actinic keratosis (Grade I/II) of the face, forehead, and balding scalp; Ozanex for the topical treatment of impetigo; Vaniqa, a topical cream for the slowing of the growth of unwanted facial hair in women; Durela, an opioid analgesic for the management of moderate to moderately severe pain in adults; Brinavess for the rapid conversion of onset atrial fibriallation to sinus rhythm in adults; and Aggrastat, a reversible GP IIb/IIIa inhibitor for use in patients with Acute Coronary Syndrome. The company's licensed products comprise Absorica, an oral retinoid indicated for the treatment of f severe nodular and/or inflammatory acne, acne conglobate and recalcitrant acne; Lipofen, which is indicated as adjunctive therapy to diet to reduce elevated LDL-C, total-C, triglycerides, and Apo B, and to increase HDL-C, as well as to reduce triglycerides in adult patients; and Conzip, an opioid agonist indicated for the management of moderate to moderately severe chronic pain in adults. Its pipeline products include MOB-015, a topical formulation of terbinafine, which is in phase 3 clinical trial for treatment of onychomycosis; CF-101 (Piclidenoson) that is in phase 3 clinical trial for severe plaque psoriasis and rheumatoid arthritis; and DTR-001, a tattoo removal cream, which is in pre-clinical stage. Cipher Pharmaceuticals Inc. was founded in 2000 and is headquartered in Mississauga, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Craig J. Mull", "title": "Interim CEO & Chairman of the Board", "fiscalYear": 2023, "totalPay": 80144, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bryan  Jacobs", "title": "President", "fiscalYear": 2023, "totalPay": 303281, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ryan  Mailling", "title": "Chief Financial Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Emilio  Presti", "title": "Director of Sales & Marketing", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Hamed  Ghanei", "title": "Chief Business Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Shengnan  Guo", "title": "Corporate Controller", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 8.37, "open": 8.8, "dayLow": 8.6, "dayHigh": 9.47, "regularMarketPreviousClose": 8.37, "regularMarketOpen": 8.8, "regularMarketDayLow": 8.6, "regularMarketDayHigh": 9.47, "payoutRatio": 0.0, "beta": 1.14, "trailingPE": 15.031747, "forwardPE": 18.94, "volume": 8227, "regularMarketVolume": 8227, "averageVolume": 16603, "averageVolume10days": 14710, "averageDailyVolume10Day": 14710, "bid": 9.42, "ask": 9.47, "bidSize": 400, "askSize": 400, "marketCap": 242716112, "fiftyTwoWeekLow": 5.62, "fiftyTwoWeekHigh": 14.6, "priceToSalesTrailing12Months": 9.172598, "fiftyDayAverage": 9.065, "twoHundredDayAverage": 9.56735, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 245309344, "profitMargins": 0.59922004, "floatShares": 14833181, "sharesOutstanding": 25589500, "sharesShort": 11427, "sharesShortPriorMonth": 48425, "sharesShortPreviousMonthDate": 1477872000, "dateShortInterest": 1480464000, "sharesPercentSharesOut": 0.0004, "heldPercentInsiders": 0.41959998, "heldPercentInstitutions": 0.01503, "shortRatio": 0.97, "impliedSharesOutstanding": 25630000, "bookValue": 3.863, "priceToBook": 2.4514627, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "earningsQuarterlyGrowth": -0.96, "netIncomeToCommon": 15856000, "trailingEps": 0.63, "forwardEps": 0.5, "enterpriseToRevenue": 9.271, "enterpriseToEbitda": 19.511, "52WeekChange": 0.28967643, "SandP52WeekChange": 0.07465422, "quoteType": "EQUITY", "currentPrice": 9.47, "recommendationKey": "none", "totalCash": 9524000, "totalCashPerShare": 0.372, "ebitda": 12573000, "totalDebt": 40752000, "quickRatio": 1.567, "currentRatio": 2.003, "totalRevenue": 26461000, "debtToEquity": 41.223, "revenuePerShare": 1.085, "returnOnAssets": 0.05055, "returnOnEquity": 0.17977, "grossProfits": 21375000, "freeCashflow": -78524128, "operatingCashflow": 13078000, "earningsGrowth": -0.963, "revenueGrowth": 0.709, "grossMargins": 0.80779, "ebitdaMargins": 0.47515, "operatingMargins": 0.18033001, "financialCurrency": "USD", "symbol": "CPHRF", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "regularMarketTime": 1742411275, "corporateActions": [], "exchange": "OQX", "messageBoardId": "finmb_8201659", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1138890600000, "regularMarketChange": 1.1000004, "regularMarketDayRange": "8.6 - 9.47", "fullExchangeName": "OTC Markets OTCQX", "averageDailyVolume3Month": 16603, "fiftyTwoWeekLowChange": 3.8500004, "fiftyTwoWeekLowChangePercent": 0.68505347, "fiftyTwoWeekRange": "5.62 - 14.6", "fiftyTwoWeekHighChange": -5.13, "fiftyTwoWeekHighChangePercent": -0.35136986, "fiftyTwoWeekChangePercent": 28.967644, "earningsTimestamp": 1742333393, "earningsTimestampStart": 1742333393, "earningsTimestampEnd": 1742333393, "earningsCallTimestampStart": 1742387400, "earningsCallTimestampEnd": 1742387400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": 0.63, "epsForward": 0.5, "fiftyDayAverageChange": 0.4050007, "fiftyDayAverageChangePercent": 0.044677407, "twoHundredDayAverageChange": -0.09735012, "twoHundredDayAverageChangePercent": -0.010175244, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "regularMarketChangePercent": 13.1421795, "regularMarketPrice": 9.47, "shortName": "Cipher Pharmaceuticals, Inc.", "longName": "Cipher Pharmaceuticals Inc.", "marketState": "REGULAR", "displayName": "Cipher Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-03-19"}]